Previous close | 45.45 |
Open | 44.80 |
Bid | 42.78 x N/A |
Ask | 47.28 x N/A |
Day's range | 44.35 - 45.34 |
52-week range | 44.35 - 69.08 |
Volume | |
Avg. volume | 177,212 |
Market cap | 96.797B |
Beta (5Y monthly) | 0.35 |
PE ratio (TTM) | 12.14 |
EPS (TTM) | 3.71 |
Earnings date | 26 Jul 2024 |
Forward dividend & yield | 2.28 (4.04%) |
Ex-dividend date | 05 Oct 2023 |
1y target est | N/A |
Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2024 Results Key Financial Results Revenue: US$11.9b (up 4.7% from 1Q...
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
PRINCETON, N.J., April 26, 2024--CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine....